Manufacturing

Welcome to the Cell & Gene Therapy and Thermo Fisher Scientific Learning Center

Process Development & cGMP Manufacturing hub

Overcoming mRNA medicine supply hurdles: distributed, continuous and multi-product mRNA manufacturing in a box at high quality and low cost

Overcoming mRNA medicine supply hurdles: distributed, continuous and multi-product mRNA manufacturing in a box at high quality and low cost

Bojan Kopilovic, Mabrouka Maamra, Zoltán Kis

A practical guide to fit-for-purpose analytical development in an emerging cell therapy landscape

A practical guide to fit-for-purpose analytical development in an emerging cell therapy landscape

Damian Marshall, Jie Wei, Florian Durst

Expert Roundtable

Exploring the UK’s evolving role in commercializing cell and gene therapies

Exploring the UK’s evolving role in commercializing cell and gene therapies

Key considerations for scalable retroviral vector production—with a focus on lentivirus

Key considerations for scalable retroviral vector production—with a focus on lentivirus

Technical and regulatory opportunities and challenges for cell and gene therapies in low earth orbit: a status report

Technical and regulatory opportunities and challenges for cell and gene therapies in low earth orbit: a status report

G du Moulin, I Sands, M Anne Snow et al

How do I ensure my early-stage analytical development is ‘phase-appropriate’? Top 5 tips

How do I ensure my early-stage analytical development is ‘phase-appropriate’? Top 5 tips

Essential manufacturing scale-up considerations for cell and gene therapies

Essential manufacturing scale-up considerations for cell and gene therapies

Cryopreservation of autologous patient material for onwards manufacture

Cryopreservation of autologous patient material for onwards manufacture

Chris Leonforte

Full speed ahead: how rapid CAR-T manufacturing can shape the cell therapy landscape

Full speed ahead: how rapid CAR-T manufacturing can shape the cell therapy landscape

Mackenzie Lieberman, Kathryn Henckels

1
2
3
4
5
6
7
8
9
10
...
>
>>

Digitization: the end-to-end solution for the decentralization of advanced therapies

Digitization: the end-to-end solution for the decentralization of advanced therapies

Emmanuel Casasola, Annie Prescott, Joseph Higdon

Cell therapy clinical translation: ensuring speed to clinic while mitigating risk

Cell therapy clinical translation: ensuring speed to clinic while mitigating risk

Shreya Shukla, Richard Dennett, Steffany Dunn

Strategic human raw material selection for cell therapy manufacturing

Strategic human raw material selection for cell therapy manufacturing

Daniel Benitez-Ribas

Optimizing iPSC-derived cell therapy development

Optimizing iPSC-derived cell therapy development

Exploring the advantages of ready-to-use lipid-based gene delivery for gene-modified cell therapy

Exploring the advantages of ready-to-use lipid-based gene delivery for gene-modified cell therapy

Chesney Michels, Claire Guéguen

Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach

Alex Lei, Sabrina Carmichael

Combining CRISPR and transposon-based technologies for improved sdAb-based CAR-T therapies

Combining CRISPR and transposon-based technologies for improved sdAb-based CAR-T therapies

Begoña Diez Cabezas, Juan Roberto Rodriguez-Madoz

Optimizing plasmid DNA purification: strategies for reliable and expandable processes

Optimizing plasmid DNA purification: strategies for reliable and expandable processes

Christy Franco, Jasmina Puc

Non-viral GMP manufacturing for engineered cells at clinical and commercial scale

Non-viral GMP manufacturing for engineered cells at clinical and commercial scale

Leif Anderson, Chris Abraham

1
2
3
4
5
6
7
8
9
10
...
>
>>